Biogen (BIIB) Goodwill & Intangibles (2009 - 2026)
Biogen (BIIB) posted Goodwill & Intangibles of $20.5 billion for Q2 2026, up 31.95% on a QoQ basis from $15.5 billion in Q1 2026, and up 28.49% year-over-year from $16.0 billion in Q2 2025.
Analysis
Biogen (BIIB) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Biogen has reported Goodwill & Intangibles for 18 years, with the latest figure at $20.5 billion in Q2 2026.
- On a quarterly basis, Goodwill & Intangibles rose 28.49% year-over-year to $20.5 billion in Q2 2026; TTM through Jun 2026 was $20.5 billion, a 28.49% increase from a year earlier, with the FY2025 full-year figure at $15.7 billion, down 3.1% from the prior year.
- Goodwill & Intangibles was $20.5 billion for Q2 2026 at Biogen, up from $15.5 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $20.5 billion in Q2 2026, with the low at $7.5 billion in Q2 2023.
- Average Goodwill & Intangibles over 5 years is $13.1 billion, with a median of $14.5 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles retreated 9.63% in 2022, then surged 92.03% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $7.6 billion in 2022, then jumped by 91.89% to $14.6 billion in 2023, then grew by 10.89% to $16.2 billion in 2024, then slipped by 3.1% to $15.7 billion in 2025, then jumped by 30.87% to $20.5 billion in 2026.
- The last three Goodwill & Intangibles figures came in at $20.5 billion (Q2 2026), $15.5 billion (Q1 2026), and $15.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.51 Bn |
| Mar 31, 2026 | 15.54 Bn |
| Dec 31, 2025 | 15.67 Bn |
| Sep 30, 2025 | 15.82 Bn |
| Jun 30, 2025 | 15.96 Bn |
| Mar 31, 2025 | 16.06 Bn |
| Dec 31, 2024 | 16.17 Bn |
| Sep 30, 2024 | 16.29 Bn |
| Jun 30, 2024 | 14.46 Bn |
| Mar 31, 2024 | 14.51 Bn |
| Dec 31, 2023 | 14.58 Bn |
| Sep 30, 2023 | 14.15 Bn |
| Jun 30, 2023 | 7.53 Bn |
| Mar 31, 2023 | 7.57 Bn |
| Dec 31, 2022 | 7.60 Bn |
| Sep 30, 2022 | 7.75 Bn |
| Jun 30, 2022 | 7.82 Bn |
| Mar 31, 2022 | 7.91 Bn |
| Dec 31, 2021 | 7.98 Bn |
| Sep 30, 2021 | 8.05 Bn |